This inventor holds 3 USPTO granted patents. Top assignees: King Abdulaziz University, University of Jeddah, Helwan University. Active years: 2025.
Company Filing History:
3 out of 588 
2 out of 12 
1 out of 1 Years Active: 2025
Title: Innovations by Mohammed A Baradwan
Introduction
Mohammed A Baradwan is a notable inventor based in Jeddah, Saudi Arabia. He has made significant contributions to the field of medical research, particularly in the development of treatments for viral infections and cancer. With a total of three patents to his name, Baradwan's work addresses critical health issues affecting many individuals globally.
Latest Patents
One of his latest patents is focused on "2-aminomethylimidazole mimics of NS4A and their effect thereof on hepatitis C virus NS3 protease." This invention presents new compounds belonging to 2-substituted-1H-imidazole-4-carboxamide derivatives intended for the treatment of hepatitis C. These compounds interfere with the essential viral peptide NS4A co-enzyme function, showcasing a novel approach to combatting this global health problem. The patent includes details on chemical synthesis, spectral confirmation, and binding assays with the NS3 protein.
Another significant patent by Baradwan is for "2-(5-aminopyridin-2-yl)-N-benzylacetamides and use thereof in the treatment of acute myeloid leukemia." This invention identifies three compounds with a common molecular template that are potential anticancer therapeutic agents, specifically targeting Acute Myeloid Leukemia (AML). Compound I was designed to inhibit the growth of AML cells and induce cell death, demonstrating a dose-dependent effect on various AML cell lines.
Career Highlights
Baradwan has worked with prominent institutions such as King Abdulaziz University and the University of Jeddah. His research has contributed to advancements in medical treatments, particularly in oncology and virology.
Collaborations
He has collaborated with notable colleagues, including Abdelsattar Mansour Omar and Roaa M Alreemi, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Mohammed A Baradwan's innovative work in developing treatments for hepatitis C and acute myeloid leukemia highlights his significant contributions to medical science. His patents reflect a commitment to addressing critical health challenges through research and innovation.